Bausch Health Companies Inc.
Price data unavailable
Track BHC in your trading journalAbout Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC) is a publicly traded US company. Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
The company reports trailing twelve-month revenue of $2.00B and net loss of $1.42B.
Key metrics include a return on equity of 69.1%, a debt-to-equity ratio of -12.42.
Investors tracking BHC can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.
Fundamentals
| Revenue (TTM) | $2.00B |
| Net Income (TTM) | $-1.42B |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 69.11% |
| Debt-to-Equity | -12.42 |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·May 4
Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight
- The Motley Fool·May 1
Why Bausch Health Companies Was Crawling Higher This Week
- GlobeNewswire Inc.·Apr 20
Pheochromocytoma and Paraganglioma Market to Exhibit Growth at 7.3% CAGR by 2036 Driven by the Advent of Drug Classes Such as SSTR2 analogs, Dopamine Receptor D2 Agonists, TAAs or TSAs, and Others | DelveInsight
Want real-time analysis on BHC?
Track it free in your trading journal. Log trades, tag setups, and review your edge.